Blis Technologies Limited reported an 18% increase in revenue and a break-even EBITDA result for the first quarter ending 30 June 2023.

CEO Brian Watson said the refreshed strategy and business model are driving revenue growth and supporting the journey back to profitability.

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut, sold throughout New Zealand and in Australia, Asia, Europe and the USA.

See more